1-(Phenylsulfonyl)-1H-pyrrolo[2,3-b]pyridine-6-carbonitrile, 95.0%, 1g

4-Methoxy-N-(4H-1,2,4-triazol-4-yl)benzamide, 90.0%, 100mg

Methyl 4-amino-1-ethyl pyrrole-2-carboxylatehydrochloride, 5g

2-Bromo-4-(trifluoromethyl)benzaldehyde, 95.0%, 10g

1-Methyl-4-((3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)sulfonyl)piperazine, 95%, 250mg

Cis-1-N-Cbz-1,4-Cyclohexyldiamine, 95.0%, 250mg

Microliter syringe MICROLITER® series 700 Point type 3, 50 µl, 705 NR, 1 piece

6,7-dihydrothieno[3,2-d]pyrimidin-2-amine, 95.0%, 1g

2-(3-Methoxyphenyl)-2-methylbutanoic acid, >95%, 1g

4-Nitrophenyl beta-D-Fucopyranoside>98.0%(GC)100mg

Ethyl 4-methylenecyclohexanecarboxylate, 95.0%, 25g

2-Cyanophenylacetonitrile, 95.0%, 25g

4-Bromo-1,2,3,6,7,8-hexahydropyrene, 96% GC, 100mg